Bionano Genomics is risky and its valuation does not justify its price. There is no compelling argument for a buy in BNGO stock.
With Bionano's disruptive tool, Saphyr, poised to revolutionize the DNA analysis sector, investors should definitely look to buy BNGO stock on its recent dip. The post You'd Be Wrong to Paint Bionano
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.
SAN DIEGO, July 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that two peer-reviewed studies from world renowned scientists and clinicians from prestigious institu
Analysts for these sought-after companies foresee upside ranging from 105% to 144% over the next year.
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.72, moving -1.47% from the previous trading session.
SAN DIEGO, July 02, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Chief Medical Officer Dr. Alka Chaubey and current President of the Cancer Genomics Consortium D
SAN DIEGO, July 01, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the 2021 Ladenburg Thalmann Healthcare Conference b
Current & Former Penny Stocks With High Marks From Analysts Right Now. The post 7 Hot Penny Stocks Analysts Like To Watch In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | P
BNGO stock has established a reliable trading range. Even long-term investors can game it while they wait for their long-term reward.
Bionano Genomics (BNGO) stock is getting a boost on Monday from a couple of new pieces of news that traders will want to know. The post BNGO Stock: 2 Big Reasons Bionano Genomics Fans Should Be Cheeri
With the "story" behind it still years in the making, take your time with BNGO stock. At some point, its meme stock investors will cash out, sending it back to more reasonable prices.
A popular trade on social media, BNGO stock has some bullish catalysts. But the primary spark, the short squeeze, might not fire.
As Bionano's Saphyr system gains international recognition, BNGO stock deserves another chance at breaking through $15 and beyond. The post Geographic Expansion Enables Healthy Diagnosis for Bionano G
In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $7.15, marking a -1.38% move from the previous day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE